XML 24 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
OPERATING ACTIVITIES:  
Net Loss attributable to the Company$ (640,931)$ (999,438)
Add: Net loss attributable to non-controlling interest(1,987)2,151
Net Loss(642,918)(997,287)
Adjustments to reconcile net loss to net cash used in operating activities:  
Depreciation and amortization60,51377,497
Bad debt expense0100,870
Amortization of debt discount052,870
Share-based compensation211,402241,868
Amortization of deferred compensation52,788929,235
Change in fair value of derivative liability0(11,208)
Rescission of research and development technology0(902,500)
(Gain) loss on sale of equipment1,119(5,919)
Changes in operating assets and liabilities:  
(Increase) Decrease in accounts receivable(23,240)5,790
Decrease in prepaid expenses and other assets2,862122,899
(Increase) in inventory(1,024) 
Increase in accounts payable and accrued expenses158,419324,233
(Decrease) in obligations to issue common stock0(18,500)
Decrease in security deposits2,200 
(Decrease) in deferred revenue(53,940)(199,022)
Net cash used in operating activities(231,819)(279,174)
INVESTING ACTIVITIES:  
Proceeds from liquidation of investments 3,563,062
Purchase of equipment (2,060)
Proceeds from sale of equipment20,000122,030
Net cash provided from investing activities20,0003,683,032
FINANCING ACTIVITIES:  
Redemption of Series B Preferred Stock (3,250,000)
Redemption of Common Stock (313,063)
Payment for Notes Receivable (20,000)
Proceeds from sale of common stock127,50075,000
Proceeds from Loan Payables42,04051,745
Payments of Loan Payables(1,412)(7,500)
Proceeds from Convertible Notes Payable 95,000
Other3,591 
Payments of Notes Payable(5,975)(48,166)
Net Cash used in Financing Activities165,744(3,416,984)
Effect of exchange rate change351 
Net decrease in cash and cash equivalents(45,724)(13,126)
Cash and cash equivalents at beginning of period61,17913,126
Cash and cash equivalents at end of period15,455 
Cash paid during the period for:  
Interest expense10,4225,084
Income tax  
Non Cash Financing Activities:  
Dividend payable on preferred stock - Series B 60,102
Discount on convertible debt 95,000
Reversal of dividends payable on preferred stock - Series B 265,787
Forgiveness of compensation700,269 
Accrued expenses applied for option exercise1,000 
Derivative Liability 57,364
Officer
  
Non Cash Financing Activities:  
Common stock issued366,000275,000
Accrued expenses
  
Non Cash Financing Activities:  
Common stock issued$ 20,875$ 6,000